Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series

Salvatore Maria Corsello, Alfredo Pontecorvi, Laura Balia, Daniela Colucci, Remo Battendieri, Mariangela Gari, Anna Dickmann Rossi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

10 Citazioni (Scopus)

Abstract

The aim of this paper was to examine the efficacy and the safety of intraorbital administration of the monoclonal anti-CD20 antibody rituximab (RTX) to treat patients affected by thyroid-associated orbitopathy (TAO) unresponsive to conventional therapy.
Lingua originaleEnglish
pagine (da-a)173-179
Numero di pagine7
RivistaMinerva Endocrinologica
Volume38
Stato di pubblicazionePubblicato - 2013

Keywords

  • Adult
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Eye Diseases
  • Female
  • Graves Ophthalmopathy
  • Humans
  • Injections
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Orbit
  • Prospective Studies
  • Thyroid Diseases
  • Thyroid Function Tests
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series'. Insieme formano una fingerprint unica.

Cita questo